TXNM Energy enters its July 31 earnings report with one of the more interesting divergences in the utility space: short sellers have been cutting positions sharply even as options traders have quietly grown more cautious.
The short-side retreat is the clearest move of the week. Short interest has fallen nearly 7% over seven days to 5.9% of the free float — down from a recent peak above 7.2 million shares in late June. That unwind is happening in a lending market with no real friction: borrow availability is extremely loose at over 2,000% of short interest, meaning supply far outstrips demand for the stock. Cost to borrow is low at 0.63%, and has eased 18% on the week despite spiking briefly to 1.79% around the July 4 holiday. Nothing in the lending market is pressuring shorts out — they appear to be exiting on conviction rather than cost. The ORTEX short score has tracked that shift, easing from 46.6 on July 6 to 44.1 by July 16, reflecting diminishing short-side pressure.
Options positioning pulls in a different direction. The put/call ratio has climbed to 0.65, roughly one standard deviation above its 20-day average of 0.51. That is not an extreme reading — the 52-week high sits at 4.20, so there is plenty of room for this to worsen — but the move is notable given it coincided with a sharp step-up from the 0.38 range that prevailed through late June. Some investors are paying more for downside protection as the earnings date approaches, even while short sellers reduce exposure.
The Street view on TXNM is measured and has been largely unchanged since late 2025. The consensus sits at hold, with a mean target of $61.15 against a current price of $57.41 — implying modest upside. The most recent analyst data of note comes from Jefferies downgrading in October 2025, simultaneously lifting its target from $58 to $61.25, a mixed signal that characterises the stock well: incrementally better fundamentals, but limited re-rating potential. Barclays held an Overweight through multiple target increases in early 2025, reaching $61, while Scotiabank and Mizuho sit at neutral-equivalent ratings. Note that all of this activity is more than six months old, and no fresh action has been captured since June 2026. Valuation multiples show the stock trading at about 18.5x earnings and 10.9x EV/EBITDA, with the P/E expanding roughly half a point over the past month as the stock nudged 1% higher. Factor scores offer limited encouragement: EPS momentum over 30 days ranks in the 16th percentile, and EPS surprise sits at just the 11th. The 90-day EPS momentum and the forward EPS growth score are brighter spots, both above the 69th percentile.
Institutional ownership adds an intriguing subplot. Blackstone holds an 8 million-share strategic stake — around 7.2% of shares — at the centre of a broader deal structure that the bull case hinges on: a partnership that analysts frame as credit-positive if regulatory approvals come through, with a stated 20% probability of failure cited by bears. Balyasny and Vanguard both established or significantly expanded positions in Q1 2026, with Balyasny entering with 7.1 million shares, a new holding. HBK and Pentwater also added materially in Q1. That cluster of new institutional money coming in alongside a short-interest decline suggests some investors are positioning around the deal thesis rather than despite it.
Recent earnings reactions from TXNM have been muted. The last three prints produced a next-day move of just -1.1%, +0.02%, and +0.22% respectively, with five-day drifts ranging from -2.3% to flat. The stock does not historically reprice sharply on results.
With the July 31 print approaching, the key tension is between a shrinking short base — potentially reflecting growing confidence in the Blackstone deal path — and an options market that is quietly hedging into the release. The regulatory approval timeline and any update on the deal structure are the data points that matter most for what happens next.
See the live data behind this article on ORTEX.
Open TXNM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
